Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

July 3rd, 2015: Performance of French Life Sciences and Healthcare Smallcaps, the IPO rally continues

juillet 03, 2015

Paris-Evry, France, July 3rd, 2015 – Aurgalys, a global provider for life sciences and healthcare companies through corporate finance, business development and interim management services, issued its monthly publication of its indices measuring the performance of French, Life Sciences and Healthcare smallcaps.

59 companies in the Alys France index with the inclusion of newly-listed Abivax and Amplitude Surgical. There are 4 more companies in the process of going public with Amoeba, Biocorp, Biophytis and Cellnovo. June was characterized by highly volatile markets and Alys France lost 6.9% this month. The strongest performer of the month was Oncodesign (+153%).

You can download our report on the following link:

 

 

Comments are closed.